Navigation Links
iGATE Completes Phase I Testing Of Meningitis Vaccine

Contract research firm iGATE Clinical Research International today completed the Phase I clinical trial of a new meningococcal-A conjugate vaccine. //

The project, which is being done in partnership between the World Health Organization (WHO) and the Program for Appropriate Technology in Health (PATH), an American NGO based in Seattle aimed at eliminating epidemic meningitis in sub-Saharan Africa.

Vaccine development partners include the Center for Biologics Evaluation and Research (CBER - a centre of the United States Food and Drug Administration for conjugation technology, and Serum Institute of India Limited (SIIL) for vaccine manufacturing, a company release said here today.

IGATE CRI was awarded a five-year contract by Meningitis Vaccine Project (MVP) for clinical trial services spanning Phase I to Phase III testing that will include seven clinical trials.

The new meningococcal A vaccine is manufactured by Serum Institute of India Limited (SIIL).

IGATE CRI commenced monitoring Phase I trials in September 2004 in India and expects to initiate work on Phase II trials this year. The Phase I trial of the new vaccine was conducted in 72 subjects across three sites in India, the release said.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Delhi Hospital Completes 100 Liver Transplants
2. SARS-Free Taiwan to Mark End Phase of Global Fight
3. Spray on contraceptive clears Phase I trial
4. Phase 3 trials of two multi-kinase inhibitors against cancer
5. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
6. Phase II trails of new HIV vaccine to be held in South Africa
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. Jalgaon: Third Phase Of Culling Operations Begin
9. Phase 1 Drug Trials on Humans to Be Made Public
10. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
11. Cadila to Commence Phase I Clinical Trials On ZYH2
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/25/2017)... ... , ... “Now Hiring!” is a popular phrase at Home Delivery Incontinent ... sales for over 30 consecutive years and now plans to hire more than 100 ... excitement and growth at HDIS, following the company’s acquisition by Fortune 1000 company Domtar. ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... the launch of their partnership to provide the Pharmacist eCare Plan ... platform in the country with the ability to develop the Pharmacist eCare Plan, ...
(Date:7/25/2017)... Spring Arbor, Mich. (PRWEB) , ... July 25, ... ... director of special education programs at Spring Arbor University recently co-authored and published ... of Self-Determination in Adolescents with Neonatal Brachial Plexus Palsy. Both the article and ...
(Date:7/25/2017)... ... 25, 2017 , ... Facing medical needs with a newborn boy this spring, ... a new benefit for employees that is uncommon in American business: 12 weeks of ... me and other employees as new parents. It keeps our family life more stable. ...
(Date:7/24/2017)... ... 24, 2017 , ... Engineers at the University of Maryland have invented an ... of electrical energy that the body uses. , In ordinary batteries the electrical ... electrons out of the battery is generated by moving positive ions from one end ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017 /PRNewswire/ ... University of Alberta in Edmonton, Canada ... partner journal, Schizophrenia 1 , demonstrating that AI ... schizophrenia with 74% accuracy. This retrospective analysis also ... symptoms in schizophrenia patients with significant correlation, based ...
(Date:7/21/2017)... 21, 2017  Endo International plc (NASDAQ: ... review of its manufacturing network, the Company will be ... in Huntsville, Alabama . The closure ... the next 12 to 18 months. The ... volumes of commoditized products and these restructuring actions are ...
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
Breaking Medicine Technology: